Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - From Lab to Human- a Placebo Controlled Randomized Trial.

NCT06857318 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT06857318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - From Lab to Human- a Placebo Controlled Randomized Trial.
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Completed
Start date
May 1, 2023
Completion date
January 1, 2024
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19